Abbott Laboratories (ABT) - 재무정보
| 연도 | 매출 | 영업이익 | EPS | 부채비율(%) | PER |
|---|---|---|---|---|---|
| FY2020 | $-B | $-B | - | - | - |
| FY2021 | $43.08B | $8.43B | $3.94 | 108.7% | 31.97 |
| FY2022 | $43.65B | $8.36B | $3.91 | 101.7% | 26.83 |
| FY2023 | $40.11B | $6.48B | $3.26 | 88.6% | 32.76 |
| FY2024 | $41.95B | $6.83B | $7.64 | 70.0% | 14.62 |
| 연도 | 매출 | 영업이익 | EPS | 부채비율(%) | PER |
|---|---|---|---|---|---|
| FY2020 | $-B | $-B | - | - | - |
| FY2021 | $43.08B | $8.43B | $3.94 | 108.7% | 31.97 |
| FY2022 | $43.65B | $8.36B | $3.91 | 101.7% | 26.83 |
| FY2023 | $40.11B | $6.48B | $3.26 | 88.6% | 32.76 |
| FY2024 | $41.95B | $6.83B | $7.64 | 70.0% | 14.62 |